Correlation Between Design Therapeutics and Myriad Genetics
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Myriad Genetics, you can compare the effects of market volatilities on Design Therapeutics and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Myriad Genetics.
Diversification Opportunities for Design Therapeutics and Myriad Genetics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Design and Myriad is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Myriad Genetics go up and down completely randomly.
Pair Corralation between Design Therapeutics and Myriad Genetics
Given the investment horizon of 90 days Design Therapeutics is expected to generate 1.86 times more return on investment than Myriad Genetics. However, Design Therapeutics is 1.86 times more volatile than Myriad Genetics. It trades about 0.12 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.15 per unit of risk. If you would invest 323.00 in Design Therapeutics on September 24, 2024 and sell it today you would earn a total of 302.00 from holding Design Therapeutics or generate 93.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 99.21% |
Values | Daily Returns |
Design Therapeutics vs. Myriad Genetics
Performance |
Timeline |
Design Therapeutics |
Myriad Genetics |
Design Therapeutics and Myriad Genetics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Design Therapeutics and Myriad Genetics
The main advantage of trading using opposite Design Therapeutics and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.Design Therapeutics vs. Fate Therapeutics | Design Therapeutics vs. Sana Biotechnology | Design Therapeutics vs. Caribou Biosciences | Design Therapeutics vs. Arcus Biosciences |
Myriad Genetics vs. Guardant Health | Myriad Genetics vs. Caredx Inc | Myriad Genetics vs. Castle Biosciences | Myriad Genetics vs. Sotera Health Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |